SARA PICKETT: Open Payments
NPI 1063464105 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,390 in 62 payments from 13 companies in 2025. Trend: 2023 $1,657 · 2024 $1,926 · 2025 $1,390
Food & beverage: $1,390
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $308 |
| Arcutis Biotherapeutics, Inc. | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 5 | $154 |
| Novartis Pharmaceuticals Corporation | 7 | $153 |
| Janssen Biotech, Inc. | 6 | $127 |
| UCB, Inc. | 5 | $103 |
| Amgen Inc. | 5 | $95 |
| Incyte Corporation | 4 | $80 |
| Organon LLC | 4 | $48 |
| LEO Pharma Inc. | 2 | $35 |
Products named: DUPIXENT, Zoryve, TREMFYA, COSENTYX, Bimzelx, Otezla, OPZELURA, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
